Skip to main content
Clinical Trials/NL-OMON53532
NL-OMON53532RecruitingPhase 3

Peroperative Administration of Tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce hemorrhage rates (PATRY study): a randomized controlled trial - PATRY

Franciscus Ziekenhuis0 sites1,524 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
1,524

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria: Primary metabolic procedure; >=18 years; good command
  • of the Dutch or English language.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study: Patients unwilling to give informed consent,
  • patients with a medical history of bleeding or VTE (defined as, pulmonary
  • embolism (PE) or deep vein thrombosis (DVT)) and patients who use therapeutic
  • anticoagulants. Patients will also be excluded in case of peroperative arterial
  • bleeding or (iatrogenic) bleeding coming from surrounding organs or vascular
  • structures such as the liver or the spleen.

Investigators

Sponsor
Franciscus Ziekenhuis

Similar Trials